These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 16295644)

  • 1. Financial analysis of cardiovascular wellness program provided to self-insured company from pharmaceutical care provider's perspective.
    Wilson JB; Osterhaus MC; Farris KB; Doucette WR; Currie JD; Bullock T; Kumbera P
    J Am Pharm Assoc (2003); 2005; 45(5):588-92. PubMed ID: 16295644
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective financial analysis of wellness center from an independent community pharmacy perspective.
    Kent K; McDonough RP; Dinges B; Doucette WR
    J Am Pharm Assoc (2003); 2006; 46(4):447-52. PubMed ID: 16913387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the cost of the Medicare Pharmacist Services Coverage Act of 2001.
    Poole VH; Moran DW; Webb CE
    Pharmacotherapy; 2003 Aug; 23(8):955-65. PubMed ID: 12921241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of a pharmacist-managed hypertension program on health system costs: an evaluation of the Study of Cardiovascular Risk Intervention by Pharmacists-Hypertension (SCRIP-HTN).
    Houle SK; Chuck AW; McAlister FA; Tsuyuki RT
    Pharmacotherapy; 2012 Jun; 32(6):527-37. PubMed ID: 22552863
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retrospective financial analysis of a herpes zoster vaccination program from an independent community pharmacy perspective.
    Wood HM; McDonough RP; Doucette WR
    J Am Pharm Assoc (2003); 2009; 49(1):12-7. PubMed ID: 19196591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program.
    Cranor CW; Christensen DB
    J Am Pharm Assoc (Wash); 2003; 43(2):149-59. PubMed ID: 12688433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Community pharmacist led, employer-based wellness services: A pilot study.
    Gatwood J; Hanley R; Moore JS; Hohmeier K
    Res Social Adm Pharm; 2019 May; 15(5):615-618. PubMed ID: 29909933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs, commitment and locality: a comparison of for-profit and not-for-profit health plans.
    Inquiry; 2004; 41(2):116-29. PubMed ID: 15449428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PharmacistCARE: description of a pharmacist care service and lessons learned along the way.
    Divine H; Nicholas A; Johnson CL; Perrier DG; Steinke DT; Blumenschein K
    J Am Pharm Assoc (2003); 2008; 48(6):793-802. PubMed ID: 19019810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacist-provided immunization compensation and recognition: white paper summarizing APhA/AMCP stakeholder meeting.
    Skelton JB; ;
    J Am Pharm Assoc (2003); 2011; 51(6):704-12. PubMed ID: 22068191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reimbursement model for pharmacist-directed medication therapy management.
    Lloyd KB; Evans RL
    J Am Pharm Assoc (2003); 2012; 52(2):161-9. PubMed ID: 22370378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective financial analysis of medication therapy management services from the pharmacy's perspective.
    McDonough RP; Harthan AA; McLeese KE; Doucette WR
    J Am Pharm Assoc (2003); 2010; 50(1):62-6. PubMed ID: 20097640
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developing a mobile pharmacist-conducted wellness clinic for rural Montana communities.
    Stratton TP; Williams RG; Meine KL
    J Am Pharm Assoc (2003); 2005; 45(3):390-9. PubMed ID: 15991761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Cost Analysis and Cost-Utility Analysis of a Community Pharmacist-Led Intervention on Reducing Cardiovascular Risk: The Alberta Vascular Risk Reduction Community Pharmacy Project (R
    Tam-Tham H; Clement F; Hemmelgarn BR; Manns BJ; Klarenbach SW; Tonelli M; Tsuyuki RT; Al Hamarneh YN; Penko J; Weaver CGW; Au F; Weaver RG; Jones CA; McBrien KA
    Value Health; 2019 Oct; 22(10):1128-1136. PubMed ID: 31563255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of pharmacy and pharmacist characteristics on the secondary prevention of cardiovascular disease.
    Puspitasari HP; Aslani P; Krass I
    Int J Clin Pharm; 2015 Oct; 37(5):834-43. PubMed ID: 25964140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and economic outcomes of a pilot project examining pharmacist-focused collaborative care treatment for depression.
    Finley PR; Bluml BM; Bunting BA; Kiser SN
    J Am Pharm Assoc (2003); 2011; 51(1):40-9. PubMed ID: 21247825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medical cost savings for web-based wellness program participants from employers engaged in health promotion activities.
    Williams LC; Day BT
    Am J Health Promot; 2011; 25(4):272-80. PubMed ID: 21361813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacy-based health promotion programme in hypertension: cost-benefit analysis.
    Côté I; Grégoire JP; Moisan J; Chabot I; Lacroix G
    Pharmacoeconomics; 2003; 21(6):415-28. PubMed ID: 12678568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medication therapy management and condition care services in a community-based employer setting.
    Johannigman MJ; Leifheit M; Bellman N; Pierce T; Marriott A; Bishop C
    Am J Health Syst Pharm; 2010 Aug; 67(16):1362-7. PubMed ID: 20689127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of an imaging-based streamlined electronic healthcare process on quality and costs.
    Bui AA; Taira RK; Goldman D; Dionisio JD; Aberle DR; El-Saden S; Sayre J; Rice T; Kangarloo H
    Acad Radiol; 2004 Jan; 11(1):13-20. PubMed ID: 14746397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.